(Press-News.org) Embargoed for release until 5:00 p.m. ET on Monday 29 December 2025
Follow @Annalsofim on X, Facebook, Instagram, Bluesky, and LinkedIn
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.
----------------------------
1. Statins significantly reduce mortality risk for adults with diabetes, regardless of cardiovascular risk
Abstract: https://www.acpjournals.org/doi/10.7326/ANNALS-25-00662
URL goes live when the embargo lifts
A large cohort study found that statins significantly reduce the risk of death and major cardiovascular events in adults with type 2 diabetes, even among those with low predicted 10-year cardiovascular risk. The findings challenge long-standing uncertainty about whether patients at the lowest risk benefit from preventive statin therapy, suggesting that the drugs may have broader protective value than previously assumed. The findings are published in Annals of Internal Medicine.
Researchers from the University of Hong Kong and colleagues analyzed data from the IQVIA Medical Research Data (IMRD)-UK database to evaluate the effectiveness and safety of statin initiation for primary prevention among adults with type 2 diabetes stratified by predicted 10-year risk of cardiovascular disease. The study population included people in the UK with type 2 diabetes aged 25 to 84 who were followed for up to 10 years. None of these patients had serious heart or liver problems before the study began. The researchers compared people who initiated statin use with those who did not across different levels of predicted heart disease risk. The data showed that statins lowered the chances of dying from any cause and reduced the risk of major cardiac events for all patients, even those considered at low risk. The authors noted a very small increase in myopathy was seen in one risk group, but there was no added risk of liver issues. According to the researchers, these data suggest that clinicians should consider the benefits of using statins in all adults with type 2 diabetes even when short-term predicted cardiovascular disease risk is low.
Media contacts: For an embargoed PDF, please contact Gabby Macrina at gmacrina@acponline.org. To contact corresponding author Eric Y.F. Wan please email yfwan@hku.hk.
----------------------------
2. Updated VA/DoD guidelines for CKD highlight SGLT2 inhibitors, GLP-1 RAs, and statins for risk reduction
Abstract: https://www.acpjournals.org/doi/10.7326/ANNALS-25-03499
URL goes live when the embargo lifts
The U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) updated their 2019 clinical practice guideline (CPG) for the management of chronic kidney disease (CKD), emphasizing early detection, risk stratification, and expanded pharmacologic options. Of the 23 recommendations included, 21 are new or updated from the 2019 CPG, including treatment with a sodium–glucose cotransporter 2 inhibitor (SGLT2i) or a glucagon-like peptide 1 receptor agonist (GLP-1 RA) in patients with type 2 diabetes and albuminuria. A summary of recommendations most relevant for primary care physicians is published in Annals of Internal Medicine.
To inform the 2025 updated CPG, the VA and DoD compiled a multidisciplinary work group with expertise in nephrology, internal medicine, and other specialties. The work group used a systematic review of peer-reviewed literature published from 14 September 2018 to 30 June 2024 to develop recommendations. Key recommendations include the use both estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (UACR) for diagnosis and risk prediction; the use of a validated kidney failure risk prediction model for management of patients with G3 to G5 CKD; shared decision-making for kidney replacement therapy; and an interdisciplinary care team and early referral to nephrology for patients with progressive CKD. 11 recommendations concerned pharmacological management, including strong recommendations for use of statins in patients with CKD not on dialysis; use of either an angiotensin-converting enzyme inhibitor (ACE-I) or an angiotensin II receptor blocker (ARB) in patients with hypertension and albuminuria; and referral of patients with autosomal-dominant polycystic kidney disease (ADPKD) to nephrology to consider tolvaptan.
Media contacts: For an embargoed PDF, please contact Gabby Macrina at gmacrina@acponline.org. To contact corresponding author James Sall, PhD please email James.Sall@va.gov.
----------------------------
Also new this issue:
Management of Conflicts of Interest in Practice Guidelines: Time to Also Account for Open-Mindedness?
Elie A. Akl, MD, MPH, PhD; Zachary Munn, BMedRad, GradDip HlthSc, MPH, PhD; and Joanne Khabsa, BS Pharm, MPH
Ideas and Opinions
Abstract: https://www.acpjournals.org/doi/10.7326/ANNALS-25-02802
The Pharmaceutical Industry’s Quiet Win in the One Big Beautiful Bill Act
Shria Bucha, BA; Matthew J. Martin, MA; and William B. Feldman, MD, DPhil, MPH
Ideas and Opinions
Abstract: https://www.acpjournals.org/doi/10.7326/ANNALS-25-03558
END
Statins significantly reduce mortality risk for adults with diabetes, regardless of cardiovascular risk
2025-12-29
ELSE PRESS RELEASES FROM THIS DATE:
Brain immune cells may drive more damage in females than males with Alzheimer’s
2025-12-29
More than seven million Americans have Alzheimer’s disease, and two-thirds of them are women, according to the Alzheimer’s Association. The O’Banion Lab at the Del Monte Institute for Neuroscience at the University of Rochester has long been studying this disease and is looking more closely at the differences between male and female brains.
“It is well documented that males and females are diagnosed with Alzheimer’s disease at different rates,” said M. Kerry O’Banion, MD, PhD, professor of Neuroscience and Neurology. “But we still do ...
Evidence-based recommendations empower clinicians to manage epilepsy in pregnancy
2025-12-29
PITTSBURGH, Dec. 29, 2025 – For the first time, clinicians have access to a clear, evidence-based roadmap for adjusting antiseizure medication doses during pregnancy and after childbirth.
The strategies, practiced by a group of leading women’s neurology experts in the nationwide landmark Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) study, were published today in Neurology. They are expected to inform clinical ...
Fungus turns bark beetles’ defenses against them
2025-12-29
Spruce bark is rich in phenolic compounds that protect trees from pathogenic fungi. A research team at the Max Planck Institute for Chemical Ecology in Jena investigated how these plant defenses function within the food web, particularly in spruce bark beetles (Ips typographus), which ingest the compounds through their diet. Could the beetles use substances from the spruce's defenses to protect themselves against pathogenic fungi?
Beetles convert plant defenses into even more toxic forms
Using state-of-the-art analytical methods such ...
There are new antivirals being tested for herpesviruses. Scientists now know how they work
2025-12-29
At a glance:
Study uncovers key insights about how a new class of antiviral drugs works.
Cryo-EM images showed the drugs bound to herpes simplex virus (HSV) protein at nearly atomic detail, while optical tweezers experiments showed how the drug-bound protein behaved in real time.
Findings could open doors to additional drugs for herpesviruses and other DNA viruses.
Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.
The discovery sheds light on an important tool for fighting drug-resistant strains of herpes simplex virus, or HSV, and points to new pathways for treating herpesviruses ...
CDI scientist, colleagues author review of global burden of fungus Candida auris
2025-12-29
The fungal species Candida auris is spreading across the globe, and gaining in virulence, according to a new review by a Hackensack Meridian Center for Discovery and Innovation (CDI) scientist and colleagues.
But there are strategies available and underway to combat the invasive and drug resistant germ, according to the new review in the American Society of Microbiology journal Microbiology and Molecular Biology Reviews.
The paper summarizes and analyzes the latest developments - and needs - in mycology in 2025. Neeraj Chauhan, Ph.D., of ...
How does stroke influence speech comprehension?
2025-12-29
Following stroke, some people experience a language disorder that hinders their ability to process speech sounds. How do their brains change from stroke? Researchers led by Laura Gwilliams, faculty scholar at the Wu Tsai Neuroscience Institute and Stanford Data Science and assistant professor at the Stanford School of Humanities and Sciences, and Maaike Vandermosten, associate professor at the Department of Neurosciences at KU Leuven, compared the brains of 39 patients following stroke and ...
B cells transiently unlock their plasticity, risking lymphoma development
2025-12-29
Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During their preparation for this battle, B cells transiently revert to a more flexible, or plastic, stem-cell-like state in the lymph nodes, according to a new preclinical study from Weill Cornell Medicine investigators. The results could help explain how many lymphomas develop from mature B cells rather than from stem cells, as many other cancers do, and guide researchers in developing better treatments.
The study, published Dec. 29 in Nature Cell Biology, reveals a paradox: as mature B cells get prepped to make antibodies, a highly specialized ...
Advanced AI dodel predicts spoken language outcomes in deaf children after cochlear implants
2025-12-29
AI model using deep transfer learning – the most advanced form of machine learning – predicted with 92% accuracy spoken language outcomes at one-to-three years after cochlear implants (implanted electronic hearing device), according to a large international study published in JAMA Otolaryngology-Head & Neck Surgery.
Although cochlear implantation is the only effective treatment to improve hearing and enable spoken language for children with severe to profound hearing loss, spoken language development after early implantation is more variable in comparison to children born with typical hearing. If children who are likely to have more ...
Multimodal imaging-based cerebral blood flow prediction model development in simulated microgravity
2025-12-29
“Maintaining adequate CBF is crucial for astronauts’ cognitive function during long-duration microgravity, but real-time monitoring in space is constrained by MRI’s complexity and payload limits,” explained study corresponding author Lijun Yuan from Air Force Medical University. The core innovations include (a) using −6° head-down tilt bed rest (HDTBR) to simulate microgravity, (b) integrating carotid ultrasound and brain MRI data to establish ML-based CBF prediction models, and (c) developing an interpretable web application for in-orbit ...
Accelerated streaming subgraph matching framework is faster, more robust, and scalable
2025-12-29
Graphs are widely used to represent complex relationships in everyday applications such as social networks, bioinformatics, and recommendation systems, where they model how people or things (nodes) are connected through interactions (edges). Subgraph matching—the task of finding a smaller pattern, or query subgraph, within a larger graph—is crucial for detecting fraud, recognizing patterns, and performing semantic searches. However, current research on streaming subgraph, a similar task where timing is important, matching faces major challenges in scalability and latency, including difficulties in handling large graphs, low cache efficiency, limited query result reuse, and ...